Literature DB >> 26319418

Kupffer cells modulate hepatic fatty acid oxidation during infection with PR8 influenza.

Tatyana N Tarasenko1, Larry N Singh2, Milani Chatterji-Len1, Patricia M Zerfas3, Kristina Cusmano-Ozog4, Peter J McGuire5.   

Abstract

In response to infection, patients with inborn errors of metabolism may develop a functional deterioration termed metabolic decompensation. The biochemical hallmarks of this disruption of metabolic homeostasis are disease specific and may include acidosis, hyperammonemia or hypoglycemia. In a model system previously published by our group, we noted that during influenza infection, mice displayed a depression in hepatic mitochondrial enzymes involved in nitrogen metabolism. Based on these findings, we hypothesized that this normal adaptation may extend to other metabolic pathways, and as such, may impact various inborn errors of metabolism. Since the liver is a critical organ in inborn errors of metabolism, we carried out untargeted metabolomic profiling of livers using mass spectrometry in C57Bl/6 mice infected with influenza to characterize metabolic adaptation. Pathway analysis of metabolomic data revealed reductions in CoA synthesis, and long chain fatty acyl CoA and carnitine species. These metabolic adaptations coincided with a depression in hepatic long chain β-oxidation mRNA and protein. To our surprise, the metabolic changes observed occurred in conjunction with a hepatic innate immune response, as demonstrated by transcriptional profiling and flow cytometry. By employing an immunomodulation strategy to deplete Kupffer cells, we were able to improve the expression of multiple genes involved in β-oxidation. Based on these findings, we are the first to suggest that the role of the liver as an immunologic organ is central in the pathophysiology of hepatic metabolic decompensation in inborn errors of metabolism due to respiratory viral infection.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Fatty acids; Influenza; Innate immune response; Metabolism; β-oxidation

Year:  2015        PMID: 26319418      PMCID: PMC6662236          DOI: 10.1016/j.bbadis.2015.08.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  The liver is a metabolic and immunologic organ: A reconsideration of metabolic decompensation due to infection in inborn errors of metabolism (IEM).

Authors:  Tatyana N Tarasenko; Peter J McGuire
Journal:  Mol Genet Metab       Date:  2017-06-24       Impact factor: 4.797

2.  Presumed acute fatty liver of pregnancy following influenza A hepatitis.

Authors:  Adam Morton
Journal:  Obstet Med       Date:  2017-04-11

3.  Macrophage derived TNFα promotes hepatic reprogramming to Warburg-like metabolism.

Authors:  Tatyana N Tarasenko; Maxim Jestin; Shingo Matsumoto; Keita Saito; Sean Hwang; Oksana Gavrilova; Niraj Trivedi; Patricia M Zerfas; Emanuele Barca; Salvatore DiMauro; Julien Senac; Charles P Venditti; Murali Cherukuri; Peter J McGuire
Journal:  J Mol Med (Berl)       Date:  2019-05-03       Impact factor: 4.599

Review 4.  Impact of pregnancy on inborn errors of metabolism.

Authors:  Gisela Wilcox
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

Review 5.  Metabolic host response and therapeutic approaches to influenza infection.

Authors:  Mohsen Keshavarz; Farid Solaymani-Mohammadi; Haideh Namdari; Yaser Arjeini; Mohammad Javad Mousavi; Farhad Rezaei
Journal:  Cell Mol Biol Lett       Date:  2020-03-05       Impact factor: 5.787

6.  Defining the kinetic effects of infection with influenza virus A/PR8/34 (H1N1) on sphingosine-1-phosphate signaling in mice by targeted LC/MS.

Authors:  Divyavani Gowda; Marumi Ohno; Siddabasave Gowda B Gowda; Hitoshi Chiba; Masashi Shingai; Hiroshi Kida; Shu-Ping Hui
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

7.  Investigating the effects of Liushen Capsules on the metabolome of seasonal influenza: A randomized clinical trial.

Authors:  Qinhai Ma; Ruihan Chen; Biao Lei; Feng Ye; Zhengtu Li; Yangqing Zhan; Bin Liu; Zifeng Yang
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

8.  Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity.

Authors:  Maxim Jestin; Senta M Kapnick; Tatyana N Tarasenko; Cassidy T Burke; Patricia M Zerfas; Francisca Diaz; Hilary Vernon; Larry N Singh; Ronald J Sokol; Peter J McGuire
Journal:  Mol Metab       Date:  2020-03-26       Impact factor: 7.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.